Rheumatologist to lead Canadian arthritis network - Laboratory Products News
January 22, 2007| Rheumatologist to lead Canadian arthritis network Laboratory Products News, Canada - ... his work has altered the treatment of this disease for many patients. Osteoarthritis and rheumatoid arthritis round out his areas of research interest. ... |
Pharmos Announces Clinical Data from Phase 2a Trial of Cannabinor ... - Drug Newswire (press release)
January 22, 2007| Pharmos Announces Clinical Data from Phase 2a Trial of Cannabinor ... Drug Newswire (press release), CT - Pharmos is developing its CB2 agonists as treatments for chronic pain and autoimmune diseases, such as multiple sclerosis and rheumatoid arthritis. ... |
Targeted Genetics Announces Publication of Inflammatory Arthritis ... - PipelineReview.com (press release)
January 22, 2007| Targeted Genetics Announces Publication of Inflammatory Arthritis ... PipelineReview.com (press release), Spain - Tumor necrosis factor alpha (TNF-alpha) is a major proinflammatory cytokine that is overproduce in rheumatoid arthritis joints by activated moncytes, ... |
Trubion Announces Completion Of Enrollment And Dosing Of Patients ... - Medical News Today (press release)
January 22, 2007| Trubion Announces Completion Of Enrollment And Dosing Of Patients ... Medical News Today (press release), UK - ... for its lead product candidate, TRU-015, which is currently being tested in a Phase IIb clinical trial for the treatment of rheumatoid arthritis. ... |
Organon and the Academic Medical Center Jointly Develop Novel ... - PharmaLive.com (press release)
January 22, 2007| Organon and the Academic Medical Center Jointly Develop Novel ... PharmaLive.com (press release), PA - 10, 2007--Organon announced a research collaboration with the Academic Medical Center (AMC) on a novel therapy for the treatment of rheumatoid arthritis. ... |
100000 suffer from rheumatoid arthritis - China Post
January 22, 2007| 100000 suffer from rheumatoid arthritis China Post, Taiwan - According to doctors, there is no known cure for rheumatoid arthritis. At present, treatment of rheumatoid arthritis is only aimed at reducing inflammation ... |
Trubion finishes recruitment in arthritis trial - Pharmaceutical Business Review
January 22, 2007| Trubion finishes recruitment in arthritis trial Pharmaceutical Business Review - ... and dosing of patients in its phase IIb trial of its lead Small Modular ImmunoPharmaceutical drug candidate for the treatment of rheumatoid arthritis. ... |